Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 06 04:00PM ET
4.49
Dollar change
+0.28
Percentage change
6.65
%
IndexRUT P/E- EPS (ttm)-0.94 Insider Own18.56% Shs Outstand49.08M Perf Week-5.87%
Market Cap255.57M Forward P/E- EPS next Y-1.28 Insider Trans-1.39% Shs Float43.47M Perf Month-21.09%
Income-111.30M PEG- EPS next Q-0.32 Inst Own74.09% Short Float5.28% Perf Quarter-23.51%
Sales9.36M P/S27.30 EPS this Y6.43% Inst Trans-1.66% Short Ratio10.53 Perf Half Y-46.42%
Book/sh4.29 P/B1.05 EPS next Y-0.98% ROA-34.81% Short Interest2.30M Perf Year-33.38%
Cash/sh4.76 P/C0.94 EPS next 5Y- ROE-55.92% 52W Range3.92 - 9.69 Perf YTD-22.98%
Dividend Est.- P/FCF- EPS past 5Y-23.71% ROI-35.27% 52W High-53.66% Beta0.78
Dividend TTM- Quick Ratio9.56 Sales past 5Y230.91% Gross Margin50.04% 52W Low14.54% ATR (14)0.34
Dividend Ex-Date- Current Ratio9.56 EPS Y/Y TTM23.85% Oper. Margin-1276.07% RSI (14)44.99 Volatility7.24% 7.49%
Employees154 Debt/Eq0.39 Sales Y/Y TTM-44.71% Profit Margin-1188.88% Recom1.12 Target Price12.57
Option/ShortNo / Yes LT Debt/Eq0.38 EPS Q/Q-3.84% Payout- Rel Volume1.54 Prev Close4.21
Sales Surprise-10.54% EPS Surprise20.74% Sales Q/Q-73.01% EarningsNov 12 BMO Avg Volume218.03K Price4.49
SMA20-3.75% SMA50-10.30% SMA200-30.93% Trades Volume335,694 Change6.65%
Date Action Analyst Rating Change Price Target Change
May-16-24Initiated BTIG Research Buy $12
May-13-24Initiated Needham Buy $11
Jun-22-23Initiated Wedbush Outperform $8
Dec-05-24 08:00AM
Dec-02-24 07:00AM
Nov-12-24 08:25AM
07:00AM
Nov-07-24 04:43AM
09:15AM Loading…
Nov-05-24 09:15AM
Oct-04-24 09:05AM
Aug-29-24 07:00AM
Aug-12-24 08:15AM
07:00AM
Jun-14-24 07:00AM
May-30-24 07:00AM
May-29-24 07:00AM
May-28-24 01:24PM
May-13-24 01:53PM
08:15AM Loading…
08:15AM
07:09AM
07:00AM
May-09-24 07:00AM
May-01-24 10:01AM
Apr-24-24 04:05PM
11:03AM
Apr-22-24 05:01PM
Apr-19-24 10:05AM
Apr-17-24 12:30AM
Apr-16-24 04:25PM
04:01PM
Apr-08-24 08:00AM
Apr-02-24 07:00AM
Mar-17-24 02:58PM
01:44PM Loading…
Mar-07-24 01:44PM
Mar-06-24 01:51PM
08:15AM
07:00AM
Feb-28-24 07:00AM
Feb-26-24 07:00AM
Feb-19-24 05:49AM
Feb-14-24 07:00AM
Feb-06-24 07:00AM
Jan-29-24 07:00AM
Jan-18-24 07:00AM
Jan-04-24 07:00AM
Dec-09-23 12:00PM
Dec-07-23 07:00AM
Dec-06-23 08:50AM
Dec-04-23 04:05PM
07:00AM
Dec-01-23 09:55AM
Nov-30-23 07:00AM
Nov-27-23 12:00PM
Nov-20-23 08:50AM
Nov-15-23 12:00PM
09:55AM
Nov-09-23 08:25AM
07:00AM
Nov-06-23 07:00AM
Nov-02-23 09:05AM
Oct-12-23 12:00PM
Sep-27-23 09:06AM
Sep-12-23 08:00AM
Sep-05-23 07:00AM
Aug-29-23 07:00AM
Aug-16-23 12:00PM
Aug-10-23 08:25AM
07:00AM
Jul-13-23 07:25AM
Jun-29-23 07:00AM
Jun-15-23 07:42AM
Jun-06-23 07:00AM
Jun-01-23 04:10PM
04:05PM
07:00AM
May-26-23 12:37AM
May-25-23 04:06PM
May-24-23 04:13PM
May-17-23 04:35PM
07:00AM
May-11-23 07:33AM
May-10-23 08:15AM
07:00AM
May-09-23 01:29PM
09:00AM
May-02-23 04:42PM
Apr-10-23 07:00AM
Mar-31-23 08:00AM
Mar-14-23 07:00AM
Mar-13-23 04:05PM
Mar-10-23 05:12AM
Mar-08-23 07:00AM
Mar-01-23 07:00AM
Feb-21-23 07:00AM
Jan-23-23 07:00AM
Jan-20-23 05:35AM
Jan-05-23 07:00AM
Dec-12-22 07:00AM
Dec-09-22 06:09AM
Dec-01-22 08:00AM
Nov-22-22 07:00AM
Nov-11-22 07:00AM
Nov-09-22 07:00AM
TScan Therapeutics, Inc. discovers and develops transformative T cell therapies (TCR-T) to treat liquid cancers, solid tumors and other serious diseases. Its platform identifies previously uncharacterized, clinically-derived shared T cell antigens and all off-target TCR interactions, to enable the development of efficacious TCR-Ts. The company was founded by Christoph H. Westphal, Stephen Elledge, Lea Hachigian, and Tomasz Kula in 2018 and is headquartered in Boston, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Lynx1 Capital Management LP10% OwnerNov 15 '24Buy4.349474,1145,225,547Nov 19 04:26 PM
Klencke BarbaraDirectorSep 23 '24Buy5.295,00026,45045,000Sep 24 05:26 PM
Klencke BarbaraDirectorAug 23 '24Buy5.695,00028,45035,000Aug 27 06:57 PM
Klencke BarbaraDirectorAug 26 '24Buy5.535,00027,65040,000Aug 27 06:57 PM
ZDRAVESKI ZORANSee RemarksAug 23 '24Option Exercise3.38157,186531,520169,402Aug 27 06:46 PM
ZDRAVESKI ZORANSee RemarksAug 23 '24Sale5.78164,686952,1164,716Aug 27 06:46 PM
ZDRAVESKI ZORANOfficerAug 23 '24Proposed Sale5.50164,686905,773Aug 23 05:50 PM
BARBERICH TIMOTHY JDirectorDec 18 '23Buy4.8928,830140,88166,710Dec 21 05:00 PM
BARBERICH TIMOTHY JDirectorDec 19 '23Buy4.973171,57567,027Dec 21 05:00 PM
Klencke BarbaraDirectorDec 14 '23Buy5.085,00025,40030,000Dec 18 06:01 PM